Skip to main content

Table 1 The demographics and clinical characteristics between patients with COVID-19

From: Association between obesity and clinical prognosis in patients infected with SARS-CoV-2

Characteristic

Group

P value

BMI < 24

BMI ≥ 24

Sample size, n

59

37

–

Sex (male), n (%)

31 (52.5)

23 (62.2)

0.355

Age (years)

35.41 ± 18.45

44.00 ± 17.23

0.025

Systolic blood pressure

124.84 ± 16.11

126.29 ± 15.51

0.666

Diastolic blood pressure

81.13 ± 9.61

85.57 ± 10.08

0.035

Creatine kinase

84.04 ± 112.12

169.37 ± 212.25

0.013

Serum lactic acid

1.64 ± 0.70

1.39 ± 0.65

0.123

Neutrophil count

3.33 ± 1.50

3.31 ± 1.41

0.927

Lymphocyte count

1.46 ± 1.04

1.19 ± 0.61

0.169

Hemoglobin

139.22 ± 15.07

142.51 ± 19.95

0.361

Platelet count

222.23 ± 66.42

180.89 ± 51.92

0.002

Serum creatinine

60.58 ± 19.09

70.19 ± 15.18

0.012

ALT

20.38 ± 16.65

26.22 ± 18.51

0.118

AST

21.70 ± 8.59

26.05 ± 13.88

0.065

Lactate dehydrogenase

177.82 ± 54.39

221.94 ± 73.21

0.001

Smoking tobacco, n (%)

5 (8.5)

3 (8.1)

0.950

  1. ALT Alanine aminotransferase; AST Aspartate aminotransferase